Skip to main content
test-tubes

Insights

Medical Research April 06, 2018

Telomerase key to liver regeneration, Stanford researchers find

By Krista Conger

Liver cells expressing high levels of telomerase - a protein normally associated with resistance to aging and implicated in cancers and stem cell maintenance - are necessary to regenerate the organ after normal cell turnover or in response to damage.

The liver is an amazing organ. Unlike others in the body, it has the ability to regenerate itself from as little as one-quarter of its original mass. But until recently it hasn't been exactly clear how it accomplishes this feat.

Now Stanford hematologist Steven Artandi, MD, PhD, and postdoctoral scholar Shengda Lin, PhD, have identified in mice a subpopulation of liver cells, called hepatocytes, that regenerate the organ during normal cell turnover or after damage. They've just published their results in Nature.

As Artandi explained in our release:

About 900,000 people die every year worldwide from cirrhosis, and liver cancer is the fifth-leading cause of cancer death in the United States. But our understanding of how the liver renews itself has languished in comparison to advances made in other organs.

Artandi and Lin compared the levels of telomerase - a protein often associated with resistance to aging and implicated in stem cell maintenance and cancer development - among hepatocytes in mice.

More from our release:

Lin found that, in mice, about 3-5 percent of all liver cells express unusually high levels of telomerase. The cells, which also expressed lower levels of genes involved in normal cellular metabolism, were evenly distributed throughout the liver's lobules. During regular cell turnover or after the liver was damaged, these cells proliferate in place to make clumps of new liver cells.

The researchers hope that their findings may one day lead to new therapies for the many people living with liver disease, or to combat cancer.

"You could imagine developing drugs that protect these telomerase-expressing cells, or ways to use cell therapy approaches to renew livers," Artandi said. "On the cancer side, I think that these cells are very strong candidates for a cell of origin. We are finally beginning to understand how this organ works."

Photo by Hakan Dahlstrom

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Krista-Conger

Science writer

Krista Conger

Senior science writer Krista Conger, PhD ’99, covers cancer, stem cells, dermatology, developmental biology, endocrinology, pathology, hematology, radiation oncology and LGBTQ+ issues for the office. She received her undergraduate degree in biochemistry at the University of California, Berkeley and her PhD in cancer biology from Stanford University. After completing the science writing program at UC Santa Cruz, she joined the Stanford Medicine Office of Communications in 2000. She enjoys distilling complicated scientific topics into engaging prose accessible to the layperson. Over the years, she has had chronicled nascent scientific discoveries from their inception to Food and Drug Administration approval and routine clinical use — documenting the wonder and long arc of medical research. Her writing has repeatedly been recognized with awards from the Counsel for the Advancement and Support of Education and the Association of American Medical Colleges. She is a member of the National Academy of Science Writers and a certified science editor through the Board of Editors in the Life Sciences. In her spare time, she enjoys textile arts, experimenting with new recipes and hiking in beautiful northwestern Montana, where she was raised and now lives.